Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 9,066 shares at $15.58 ($141K) on 2024-07-29, disclosed to the SEC on 2024-07-31.
Scheduled sale ($141k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.58 | 4,066 | $63K | 44.9% |
| 2 | $15.58 | 4,066 | $63K | 44.9% |
| 3 | $15.55 | 934 | $15K | 10.3% |
| Total | $15.58 avg | 9,066 | $141K | 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |